Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!
Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available!
Here come GMP Grade Cytokines!Free Sample is available!
제품번호 | 종 | 제품 설명 | 구조 | 순도 | 특징 |
---|---|---|---|---|---|
IL3-H52G3 | Human | Human IL-13 Protein, GST Tag | ![]() |
![]() ![]() |
|
IL3-C5249 | Cynomolgus | Cynomolgus IL-13 Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
|
IL3-M5249 | Mouse | Mouse IL-13 Protein, His Tag | ![]() |
![]() ![]() |
|
IL3-C52H4 | Canine | Canine IL-13 Protein, His Tag | ![]() |
![]() ![]() |
|
IL3-H82E5 | Human | Biotinylated Human IL-13 Protein, His,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
|
IL3-H5256 | Human | Human IL-13 Protein, Fc Tag | ![]() |
![]() ![]() |
|
IL3-H52H4 | Human | Human IL-13 Protein, His Tag | ![]() |
![]() ![]() |
Biotinylated Human IL-13 R alpha 1 Protein, His,Avitag (Cat. No. IL1-H82E8) captured on Biotin CAP-Series S Sensor Chip can bind Human IL-13 Protein, His Tag (Cat. No. IL3-H52H4) with an affinity constant of 34.4 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Dupilumab | SAR-231893; REGN-668 | Approved | Sanofi, Regeneron Pharmaceuticals Inc | Dupixent, 达必妥 | United States | Dermatitis, Atopic | Regeneron Pharmaceuticals Inc | 2017-03-28 | Scleroderma, Localized; Sleep Apnea Syndromes; Sinusitis; Duodenitis; Urticaria; Colitis, Ulcerative; Asthma; Pemphigoid, Bullous; Prurigo; Neurodermatitis; Paranasal Sinus Diseases; Conjunctivitis, Allergic; Pulmonary Disease, Chronic Obstructive; Asthma, Aspirin-Induced; Peanut Hypersensitivity; Hypersensitivity, Immediate; Keratoconjunctivitis; Keloid; Dermatitis, Atopic; Eczema; Hypersensitivity; Angioedema; Milk Hypersensitivity; Aspergillosis, Allergic Bronchopulmonary; Lichenoid Eruptions; Hypereosinophilic Syndrome; Gastrointestinal Diseases; Pruritus; Respiratory Sounds; Alopecia Areata; Chronic Urticaria; Respiration Disorders; Nasal Polyps; Eosinophilic gastroenteritis (EG); Respiratory Tract Diseases; Coronavirus Disease 2019 (COVID-19); Prurigo Nodularis; Dermatitis; Skin Diseases, Eczematous; Genetic Diseases, Inborn; Skin Diseases; Prostatic Neoplasms; Eosinophilic Esophagitis; Rhinitis, Allergic | Details |
Berdazimer sodium | NVN-1000-SB-206-Novan; SB-206; MAP3-NONOate - SB-206; NVN1000-SB206; SB-019; NI-MC101; SB-207; SB-208; SB-204; SB-414 | Approved | Novan Inc | Zelsuvmi, ZELSUVMI, KINSOLUSTM | United States | Molluscum Contagiosum | Lnhc Inc | 2024-01-05 | Acne Vulgaris; Tinea Pedis; Psoriasis; Molluscum Contagiosum; Condylomata Acuminata; Dermatitis, Atopic | Details |
Lebrikizumab | MILR1444Ab; R-3637; DRM 06; LY 3650150; MILR1444A; RG 3637; RO 5490255; TNX 650; Anti-IL-13; TNX-650; MILR-1444A; RG-3637; RO-5490255; RO-4909832; PRO-301444; DRM-06 | Approved | Tanox Inc | EBGLYSS | EU | Dermatitis, Atopic | Almirall Sa | 2023-11-16 | Nasal Polyps; Idiopathic Pulmonary Fibrosis; Hodgkin Disease; Skin Diseases; Dermatitis; Rhinitis, Allergic; Asthma; Sinusitis; Alzheimer Disease; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic; Skin Diseases, Genetic; Eczema | Details |
Tralokinumab | BAK-502G9; CAT-354 | Approved | Medimmune Llc | Adtralza, ADBRY | EU | Dermatitis, Atopic | Leo Pharma A/S | 2021-06-17 | Idiopathic Pulmonary Fibrosis; Asthma; Colitis, Ulcerative; Dermatitis, Atopic; Eczema | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Cendakimab | RPC-4046; ABT-308; CC-93538 | Phase 3 Clinical | Abbott Laboratories | Eosinophilic gastroenteritis (EG); Eosinophilic Esophagitis; Asthma; Dermatitis, Atopic; Eczema | Details |
Eblasakimab | MK-6105; ASLAN-004; CSL-334 | Phase 2 Clinical | Csl Ltd, Merck Sharp & Dohme Corp | Dermatitis, Atopic; Hypersensitivity | Details |
Dectrekumab/VAK-694 | QBX-258 | Phase 2 Clinical | Novartis Pharma Ag | Lymphedema; Asthma | Details |
APG777 | APG-777; PR004; PR-004; APG 777; APG777 | Phase 2 Clinical | Apogee Therapeutics Inc | Asthma; Dermatitis, Atopic | Details |
PF-07264660 | PF-07264660 | Phase 2 Clinical | Pfizer Inc | Dermatitis, Atopic | Details |
PF-07275315 | PF-07275315 | Phase 2 Clinical | Pfizer Inc | Dermatitis, Atopic | Details |
Lunsekimig | SAR-443765 | Phase 2 Clinical | Sanofi | Nasal Polyps; Asthma; Sinusitis; Inflammation; Dermatitis, Atopic | Details |
SC-CAR4BRAIN | Phase 1 Clinical | Seattle Children'S Hospital | Sarcoma, Synovial; Neoplasms, Germ Cell and Embryonal; Diffuse Intrinsic Pontine Glioma; Sarcoma, Clear Cell; Osteosarcoma; Retinoblastoma; Neuroblastoma; Neurofibrosarcoma; Sarcoma, Ewing; Sarcoma; Solid tumours; Central Nervous System Neoplasms; Wilms Tumor; Carcinoma; Rhabdoid Tumor; Hepatoblastoma; Diffuse midline glioma; Desmoplastic Small Round Cell Tumor; Rhabdomyosarcoma | Details | |
NM26-2198 | NM-26-2198; NM26-2198 | Phase 1 Clinical | Numab Therapeutics Ag | Inflammation; Dermatitis, Atopic | Details |
SAR-444765 | SAR444765; SAR-444765 | Phase 1 Clinical | Sanofi | Inflammation | Details |
CM-512 | CM512; CM-512 | Phase 1 Clinical | Keymed Biosciences Co Ltd | Nasal Polyps; Asthma; Sinusitis; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
SAR-443726 | SAR-443726 | Phase 1 Clinical | Sanofi | Dermatitis, Atopic | Details |
This web search service is supported by Google Inc.